SE0101230L - Ny användning av en tyrosinkinasinhibitor - Google Patents

Ny användning av en tyrosinkinasinhibitor

Info

Publication number: SE0101230L
Authority: SE; Sweden
Prior art keywords: tyrosine kinase; frk; inhibitor; relates; type
Prior art date: 2001-04-06

Application number

SE0101230A

Other languages

Unknown language ( )

English (en)

Other versions

SE0101230D0 (sv

Inventor

Michael Welsh

Cecilia Anneren

Original Assignee

Innoventus Project Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-06

Filing date

2001-04-06

Publication date

2002-10-07

2001-04-06 Application filed by Innoventus Project Ab filed Critical Innoventus Project Ab

2001-04-06 Priority to SE0101230A priority Critical patent/SE0101230L/sv

2001-04-06 Publication of SE0101230D0 publication Critical patent/SE0101230D0/sv

2002-04-05 Priority to EP02720710A priority patent/EP1372621B1/en

2002-04-05 Priority to AT02720710T priority patent/ATE397921T1/de

2002-04-05 Priority to DK02720710T priority patent/DK1372621T3/da

2002-04-05 Priority to DE60227058T priority patent/DE60227058D1/de

2002-04-05 Priority to US10/473,765 priority patent/US20040171563A1/en

2002-04-05 Priority to PCT/SE2002/000682 priority patent/WO2002080894A1/en

2002-10-07 Publication of SE0101230L publication Critical patent/SE0101230L/sv

Links

229940121358 tyrosine kinase inhibitor Drugs 0.000 title abstract 2
239000005483 tyrosine kinase inhibitor Substances 0.000 title abstract 2
150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 title abstract 2
101000892986 Homo sapiens Tyrosine-protein kinase FRK Proteins 0.000 abstract 5
102100040959 Tyrosine-protein kinase FRK Human genes 0.000 abstract 5
239000003112 inhibitor Substances 0.000 abstract 3
210000002237 B-cell of pancreatic islet Anatomy 0.000 abstract 2
108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 2
102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 2
206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
101100227720 Mus musculus Frk gene Proteins 0.000 abstract 1
101000994660 Rattus norvegicus Potassium voltage-gated channel subfamily A member 2 Proteins 0.000 abstract 1
101710089880 Tyrosine-protein kinase FRK Proteins 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
239000002981 blocking agent Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000002452 interceptive effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE0101230A 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor SE0101230L (sv)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
SE0101230A SE0101230L (sv)	2001-04-06	2001-04-06	Ny användning av en tyrosinkinasinhibitor
EP02720710A EP1372621B1 (en)	2001-04-06	2002-04-05	Novel use of tyrosine kinase frk inhibitor
AT02720710T ATE397921T1 (de)	2001-04-06	2002-04-05	Neue verwendung von frk-tyrosinekinase inhibitoren
DK02720710T DK1372621T3 (da)	2001-04-06	2002-04-05	Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor
DE60227058T DE60227058D1 (sv)	2001-04-06	2002-04-05
US10/473,765 US20040171563A1 (en)	2001-04-06	2002-04-05	Novel use of tyrosine kinase inhibitor
PCT/SE2002/000682 WO2002080894A1 (en)	2001-04-06	2002-04-05	Novel use of tyrosine kinase inhibitor

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0101230A SE0101230L (sv)	2001-04-06	2001-04-06	Ny användning av en tyrosinkinasinhibitor

Publications (2)

Publication Number	Publication Date
SE0101230D0 SE0101230D0 (sv)	2001-04-06
SE0101230L true SE0101230L (sv)	2002-10-07

Family

ID=20283697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0101230A SE0101230L (sv)	2001-04-06	2001-04-06	Ny användning av en tyrosinkinasinhibitor

Country Status (7)

Country	Link
US (1)	US20040171563A1 (sv)
EP (1)	EP1372621B1 (sv)
AT (1)	ATE397921T1 (sv)
DE (1)	DE60227058D1 (sv)
DK (1)	DK1372621T3 (sv)
SE (1)	SE0101230L (sv)
WO (1)	WO2002080894A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060094682A1 (en) *	2004-10-29	2006-05-04	Odyssey Thera, Inc.	Kinase inhibitors for the treatment of diabetes and obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6177401B1 (en) *	1992-11-13	2001-01-23	Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften	Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
GB9718913D0 (en) *	1997-09-05	1997-11-12	Glaxo Group Ltd	Substituted oxindole derivatives
GB9721437D0 (en) *	1997-10-10	1997-12-10	Glaxo Group Ltd	Heteroaromatic compounds and their use in medicine
EP1436259A1 (en) *	2001-09-10	2004-07-14	Congxin Liang	3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors

2001
- 2001-04-06 SE SE0101230A patent/SE0101230L/sv not_active Application Discontinuation
2002
- 2002-04-05 DK DK02720710T patent/DK1372621T3/da active
- 2002-04-05 US US10/473,765 patent/US20040171563A1/en not_active Abandoned
- 2002-04-05 WO PCT/SE2002/000682 patent/WO2002080894A1/en not_active Ceased
- 2002-04-05 EP EP02720710A patent/EP1372621B1/en not_active Expired - Lifetime
- 2002-04-05 AT AT02720710T patent/ATE397921T1/de not_active IP Right Cessation
- 2002-04-05 DE DE60227058T patent/DE60227058D1/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK1372621T3 (da)	2008-10-20
SE0101230D0 (sv)	2001-04-06
DE60227058D1 (sv)	2008-07-24
EP1372621A1 (en)	2004-01-02
WO2002080894A1 (en)	2002-10-17
ATE397921T1 (de)	2008-07-15
EP1372621B1 (en)	2008-06-11
US20040171563A1 (en)	2004-09-02

Similar Documents

Publication	Publication Date	Title
HUP0402403A2 (hu)	2005-04-28	Cukorbetegség-ellenes hatású dipeptilpeptidáz IV (DP-IV) inhibitorok ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MX2010001784A (es)	2010-03-15	Activadores novedosos de la glucocinasa.
NO20083026L (no)	2008-09-16	Terapeutisk middel for diabetes
UA88257C2 (ru)	2009-10-12	ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ
NO20051103L (no)	2005-04-08	Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer
TW200745037A (en)	2007-12-16	Organic compounds
IS7753A (is)	2005-03-17	Beta-amínó heterósýklískir dípeptidýl peptíðasa hindrar til meðhöndlunar á, eða til að fyrirbyggja,sykursýki
AU2003282234A1 (en)	2004-06-15	Benzofuran derivates, process for their preparation and intermediates thereof
MY127961A (en)	2007-01-31	Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes
DE60231407D1 (de)	2009-04-16	Hemmende antikörper der her3-aktivität
ATE514435T1 (de)	2011-07-15	Verwendung eines dpp-iv-hemmers zur minderung hypoglykämischer ereignisse
ATE358668T1 (de)	2007-04-15	Drogen zur behandlung maligner tumoren
ATE534404T1 (de)	2011-12-15	Dipeptidylpeptidase-iv-inhibitoren zur behandlung von diabetes-patienten mit sekundärversagen durch sulfonylharnstoffe
EA199901086A1 (ru)	2000-06-26	ХИНОЛИНОВЫЕ И ХИНОКСАЛИНОВЫЕ СОЕДИНЕНИЯ, ИНГИБИРУЮЩИЕ ТИРОЗИНКИНАЗЫ ТРОМБОЦИТАРНОГО ФАКТОРА РОСТА И/ИЛИ p56
PT1311504E (pt)	2005-10-31	Tetrazolil-fenil-acetamidas activadoras da glucoquinase
DE60110054D1 (en)	2005-05-19	Cardioprotektive phosphonate
MXPA04001500A (es)	2004-05-14	Compuestos que tienen un efecto sobre la glucocinasa.
BR0206831A (pt)	2004-07-06	Composto, cristal, agente farmacêutico, agentes para profilaxia ou tratamento de diabetes, de complicações diabéticas, de tolerância prejudicada à glucose e de obesidade, inibidor de peptidase, uso de um composto, e, método de produção de um composto
MY135222A (en)	2008-02-29	Substituted phenylacetamides and their use as glucokinase activators
MXPA02011079A (es)	2004-08-19	Inhibidores heterociclicos de quinasa de sintasa de glucogeno gsk3.
NO20034204D0 (no)	2003-09-22	Farmasöytiske kombinasjoner til behandling av kreft
TNSN07048A1 (en)	2008-06-02	Trifluoromethyl substituted benzamides as kinase inhibitors
MX2008000255A (es)	2008-04-02	Activadores de urea glucocinasa.
HUP0402506A2 (hu)	2005-04-28	FBPáz inhibitorok és inzulinérzékenység-fokozók kombinációja diabétesz kezelésére
Hu et al.	2009	Pharmacokinetics and pharmacodynamics of vildagliptin in healthy Chinese volunteers

Legal Events

Date	Code	Title	Description
2003-11-18	NAV	Patent application has lapsed